Bottom line
HLHIX vs PRHSX: the short answer
HLHIX (Virtus KAR Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.
But PRHSX is far broader, holding 279 positions to 24 for HLHIX, so beyond the top names it adds exposure HLHIX doesn't have.
PRHSX is cheaper at 0.83% vs 1.05% — a difference of $22 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs +3.8% for HLHIX.
Updated Nov 19, 2026
HLHIX vs PRHSX side by side
| HLHIX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Virtus | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.05% | 0.83% |
| Annual cost per $10k | $105 | $83 |
| 10-yr cost on $10k (prospectus) | $1,367 | $1,025 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | — |
| 1-yr return | +7.6% | +17.7% |
| 5-yr return (annualized) | +3.8% | +4.2% |
| 10-yr return (annualized) | +7.1% | +9.1% |
| Best quarter | +16.5% | +23.5% |
| Worst quarter | −11.8% | −15.8% |
| Net assets (fund) | $91.7M | $11.9B |
| Number of holdings | 24 | 279 |
| Portfolio turnover | 13% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HLHIX | PRHSX | Difference |
|---|---|---|---|
| 2025 | +7.6% | +17.7% | −10.1% |
| 2024 | −2.0% | +1.8% | −3.8% |
| 2023 | +2.8% | +3.1% | −0.2% |
| 2022 | −11.6% | −12.2% | +0.6% |
| 2021 | +25.7% | +13.3% | +12.5% |
| 2020 | +14.1% | +30.1% | −16.1% |
Source: Fund prospectus bar charts
Holdings overlap
9 of HLHIX's top 24 holdings also appear in PRHSX's top 25.
| Holding | HLHIX | PRHSX |
|---|---|---|
| Eli Lilly & Company | 14.84% | 14.28% |
| Abbvie Inc | 5.52% | 5.10% |
| Vertex Pharmaceuticals Inc | 5.32% | 2.28% |
| Merck & Company Inc | 5.06% | 4.01% |
| Unitedhealth Group Inc | 4.65% | 5.99% |
| Intuitive Surgical Inc | 3.89% | 1.87% |
| Amgen Inc | 3.85% | 1.82% |
| Thermo Fisher Scientific Inc | 3.65% | 2.52% |
| Danaher Corp | 3.37% | 1.43% |
Source: SEC Form N-PORT
HLHIX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between HLHIX and PRHSX?
Which is cheaper, HLHIX or PRHSX?
Should I own both HLHIX and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.